Open AccessA Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib
Author(s) -
Danielle Brazel,
Zhaohui Arter,
Misako Nagasaka
Publication year - 2022
Publication title -
lung cancer targets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.433
H-Index - 16
ISSN - 1179-2728
DOI - 10.2147/lctt.s383662
Subject(s) - kras , guanosine , tolerability , cancer research , lung cancer , gtp' , pharmacodynamics , guanosine triphosphate , targeted therapy , pharmacokinetics , medicine , cancer , pharmacology , chemistry , oncology , colorectal cancer , biochemistry , adverse effect , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom